What is Biodesix, Inc.'s R&D?

Biodesix, Inc. (BDSX) reported R&D of $3.29M in Q1 2026.

How has Biodesix, Inc.'s R&D changed year-over-year?

Biodesix, Inc.'s R&D increased by 14.5% year-over-year, from $2.87M to $3.29M.

What is the long-term trend for Biodesix, Inc.'s R&D?

Over 4 years (2021 to 2025), Biodesix, Inc.'s R&D has grown at a -1.6% compound annual growth rate (CAGR), from $12.79M to $12M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Biodesix, Inc. BDSX R&D

R&D at other companies

NeoGenomicsNEO

$9.53M-6.4%

VeracyteVCYT

$27.1M+52.9%

Adaptive BiotechnologiesADPT

$23.62M-2.4%

Personalis, Inc.PSNL

$14.54M+15.0%

Guardant HealthGH

$91.04M+2.8%

Tempus AI, Inc.TEM

$48.24M+34.5%

Other financials

Income statement

See full

Revenue$25.6M+42.3%

Operating income-$6.2M+32.1%

Net income-$7.8M+29.8%

EPS (diluted)-$0.81+46.7%

Balance sheet

See full

Cash & equivalents$25.6M+45.3%

Total debt$71.6M+15.0%

Total equity$9.1M-17.4%

Total assets$94.6M+9.7%

Cash flow

See full

Operating cash flow-$10.2M-18.2%

CapEx$81.0K+9.5%

Free cash flow-$10.2M-18.1%

Valuation

See full

Market cap$233.52M+462%

Enterprise value$279.56M+198%

P/S2.4×+1.9×

Profitability

See full

Operating margin-26%-7.5pp

Net margin-33.3%-9.3pp

FCF margin-26.8%-9.6pp

Returns & leverage

See full

Return on equity-316.5%—

Debt / equity7.8×+2.2×

Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biodesix, Inc.'s R&D?: Biodesix, Inc. (BDSX) reported R&D of $3.29M in Q1 2026.
How has Biodesix, Inc.'s R&D changed year-over-year?: Biodesix, Inc.'s R&D increased by 14.5% year-over-year, from $2.87M to $3.29M.
What is the long-term trend for Biodesix, Inc.'s R&D?: Over 4 years (2021 to 2025), Biodesix, Inc.'s R&D has grown at a -1.6% compound annual growth rate (CAGR), from $12.79M to $12M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.